May 22, 2026
American Healthcare REIT, Inc.
18191 Von Karman Avenue
Suite 300
Irvine, California 92612
Re: Registration Statement on Form S-3ASR (File No. 333-281488)
Ladies and Gentlemen:
We have served as Maryland counsel to American Healthcare REIT, Inc., a Maryland corporation (the “Company”), in connection with certain matters of Maryland law arising out of the registration of the offering and sale of up to 16,100,000 (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), pursuant to the Underwriting Agreement, dated as of May 20, 2026 (the “Underwriting Agreement”), among the Company, American Healthcare REIT Holdings, LP, a Delaware limited partnership, and BofA Securities, Inc., in its capacity as underwriter (the “Underwriter”), BofA Securities, Inc., in its capacity as forward seller (the “Forward Seller”), and Bank of America, N.A., in its capacity as forward purchaser (the “Forward Purchaser”), including up to 2,100,000 Shares that may be sold pursuant to the exercise by the Underwriter of an option to purchase additional shares of Common Stock. Pursuant to the Underwriting Agreement, the Company will issue and sell any Shares (such Shares, if and to the extent so issued and sold by the Company, the “Company Shares”) that the Forward Seller does not sell and deliver to the Underwriter. The Company will also issue, sell and/or deliver up to 24,150,000 shares of Common Stock (the “Confirmation Shares”), upon settlement of one or more Forward Sale Agreements (as defined below).
In connection with our representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (hereinafter collectively referred to as the “Documents”):



